Alex

Menzies Aviation Selects WNS to Transform their Finance Shared Services

NEW YORK & MUMBAI, India--(BUSINESS WIRE)--$WNS #BPM--WNS (Holdings) Limited (NYSE: WNS), a leading provider of…

Zai Lab Announces NDA Acceptance of Repotrectinib for Patients with ROS1-positive NSCLC by China’s NMPA

SHANGHAI, China and CAMBRIDGE, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:…

Bitdefender to Acquire Horangi Cyber Security to Expand its GravityZone Unified Risk and Security Analytics Platform

Acquisition will Extend Bitdefender Product and Services Portfolio with Cloud Infrastructure Security Management and Security…

Global Blue Reports Strong Q4 and FY2022/23 Financial Results With a Significant Improvement Across All Key Metrics

Significant improvement in Adjusted EBITDA to €78.0M in FY2022/23 vs (€9.9M) in FY2021/22, representing 46%…

Ampt Completes Repowering Project in Japan Allowing PV System to Meet New Utility Requirements

Ampt String Optimizers simplify inverter replacements and lower upgrade costs for a large rooftop PV…

WCD 2023: Galderma to Present Extensive Data Demonstrating Enduring Commitment to Delivering Innovative Solutions in Dermatology

Galderma will present 59 abstracts at the 25th World Congress of Dermatology (WCD), demonstrating the…

AstraZeneca announces $400 million investment in reforestation and biodiversity in support of climate action and human health

Expansion of AZ Forest programme raises commitment to plant 200 million trees across six continents…

Nidec Files a Civil Action and a Complaint against Toyo Keizai Inc. and Former Employee, etc.

KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594) (OTC US: NJDCY) (“Nidec” or the “Company”) announced today…

Black & Veatch Appoints Industry Veteran as President, Asia-Pacific and India as Company Continues Growth Across the Regions

Narsingh Chaudhary to succeed Hoe Wai Cheong who will retire at the end of 2023…

Microba Commences Phase I Clinical Trial for IBD Therapeutic

First participants have been successfully dosed in a Phase I Clinical Trial of MAP 315,…